Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Pharmacyclics

Two blood cancer drugs among CHMP recommendations

Two blood cancer drugs among CHMP recommendations The drug is a Bruton's tyrosine kinase (BTK) inhibitor licensed by Janssen's parent company J&J from Pharmacyclics in 2011 in a deal involving an upfront payment of $150m

GSK and Genmab's Arzerra fails lymphoma trial

GSK and Genmab's Arzerra fails lymphoma trial Meanwhile, other rivals are reaching the market, such as Johnson &Johnson/Pharmacyclics' small-molecule drug Imbruvica (ibrutinib) which was approved in the US in November 2013 as a second line treatment

FDA clears J&J's Imbruvica for leukaemia

FDA clears J&J's Imbruvica for leukaemia Ibrutinib is a Bruton's tyrosine kinase (BTK) inhibitor licensed by J&J from Pharmacyclics in 2011 in a deal involving an upfront payment of $150m plus potential development and commercial

FDA sets standard review for Gilead's idelalisib in NHL

FDA sets standard review for Gilead's idelalisib in NHL In CLL, idelalisib will compete head-to-head with Pharmacyclics and Johnson &Johnson's much-anticipated Imbruvica (ibrutinib), which acts as a Bruton's tyrosine kinase (BTK) inhibitor, a similar but

J&J's Imbruvica tops Arzerra in phase III trial

J&J's Imbruvica tops Arzerra in phase III trial Shows improvement over GSK’s drug in haematological malignancies. A trial of Johnson &Johnson (J&J) and Pharmacyclics' recently approved cancer drug Imbruvica has been halted early after it outperformed ... Ibrutinib - designated a breakthrough by the

[ Previous 5 results ] 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
Hybrid working: Insights and tips for success
Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...